Target intelligence / Profile preview

MGAT4 family member F, pseudogene (MGAT4FP)

Target
MGAT4FP
Molecular classification
Pseudogene, Non-coding RNA, Glycosyltransferase gene family (as a homolog), Other
01

Overview

MGAT4 family member F, pseudogene (MGAT4FP) is a non-protein coding transcript homologous to glycosyltransferases of the MGAT4 gene family, lacking a functional open reading frame[1][3]. In breast cancer, MGAT4FP is overexpressed, correlating strongly with poor prognosis and advanced tumor stage[1]. Experimental data suggest it acts in part as a competing endogenous RNA (ceRNA) by interacting with microRNAs and regulatory proteins to modulate gene expression of functional homologs and oncogenic transcription factors such as FOXM1[1][4]. Silencing MGAT4FP in breast cancer cell lines increases apoptosis and inhibits cell migration and tumor progression, particularly affecting key genes in the focal adhesion pathway[1]. There is currently no evidence for direct protein product, drug targeting, or utility in other disease areas, but its role as a biomarker and regulator of cancer biology has been validated[1][4]. The precise biological mechanisms and therapeutic utility remain the subject of ongoing research.

Other names
MGAT4FP
02

Mechanism of action

Not applicable; no drugs known to act directly. If targetable, it would involve knockdown strategies (siRNA/shRNA)

03

Biological functions

Regulation of apoptosisRegulation of cell migration and invasionRegulation of gene expression via microRNA competition (ceRNA function)Modulation of focal adhesion pathwaysOther
04

Disease associations

Cancer (notably breast cancer, especially metastatic and triple-negative breast cancer)Other
05

Safety considerations

None specifically noted. General challenges include the unknown effects of targeting pseudogenes and off-target regulation of homologous protein-coding genes
06

Biomarkers

MGAT4FP expression as a prognostic biomarker in breast cancer

Beyond the preview

Go deeper on MGAT4 family member F, pseudogene (MGAT4FP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MGAT4 family member F, pseudogene (MGAT4FP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call